276 related articles for article (PubMed ID: 31163212)
1. Effects of SSRIs on peripheral inflammatory cytokines in patients with Generalized Anxiety Disorder.
Hou R; Ye G; Liu Y; Chen X; Pan M; Zhu F; Fu J; Fu T; Liu Q; Gao Z; Baldwin DS; Tang Z
Brain Behav Immun; 2019 Oct; 81():105-110. PubMed ID: 31163212
[TBL] [Abstract][Full Text] [Related]
2. Peripheral proinflammatory cytokines in Chinese patients with generalised anxiety disorder.
Tang Z; Ye G; Chen X; Pan M; Fu J; Fu T; Liu Q; Gao Z; Baldwin DS; Hou R
J Affect Disord; 2018 Jan; 225():593-598. PubMed ID: 28886500
[TBL] [Abstract][Full Text] [Related]
3. The impact of antidepressants on seizure frequency and depressive and anxiety disorders of patients with epilepsy: Is it worth investigating?
Ribot R; Ouyang B; Kanner AM
Epilepsy Behav; 2017 May; 70(Pt A):5-9. PubMed ID: 28407526
[TBL] [Abstract][Full Text] [Related]
4. Persistence, switching, and discontinuation rates among patients receiving sertraline, paroxetine, and citalopram.
Mullins CD; Shaya FT; Meng F; Wang J; Harrison D
Pharmacotherapy; 2005 May; 25(5):660-7. PubMed ID: 15899727
[TBL] [Abstract][Full Text] [Related]
5. Pregabalin versus sertraline in generalized anxiety disorder. An open label study.
Cvjetkovic-Bosnjak M; Soldatovic-Stajic B; Babovic SS; Boskovic K; Jovicevic M
Eur Rev Med Pharmacol Sci; 2015; 19(11):2120-4. PubMed ID: 26125277
[TBL] [Abstract][Full Text] [Related]
6. Spotlight on paroxetine in psychiatric disorders in adults.
Wagstaff AJ; Cheer SM; Matheson AJ; Ormrod D; Goa KL
CNS Drugs; 2002; 16(6):425-34. PubMed ID: 12027788
[TBL] [Abstract][Full Text] [Related]
7. Pro-inflammatory cytokines are elevated in adolescent females with emotional disorders not treated with SSRIs.
Henje Blom E; Lekander M; Ingvar M; Åsberg M; Mobarrez F; Serlachius E
J Affect Disord; 2012 Feb; 136(3):716-23. PubMed ID: 22056230
[TBL] [Abstract][Full Text] [Related]
8. Effects of escitalopram on sleep problems in patients with major depression or generalized anxiety disorder.
Stein DJ; Lopez AG
Adv Ther; 2011 Nov; 28(11):1021-37. PubMed ID: 22057726
[TBL] [Abstract][Full Text] [Related]
9. Assessing the comparative-effectiveness of antidepressants commonly prescribed for depression in the US Medicare population.
Kaplan C; Zhang Y
J Ment Health Policy Econ; 2012 Dec; 15(4):171-8. PubMed ID: 23525835
[TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy for anxiety and comorbid alcohol use disorders.
Ipser JC; Wilson D; Akindipe TO; Sager C; Stein DJ
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007505. PubMed ID: 25601826
[TBL] [Abstract][Full Text] [Related]
11. Are SSRIs really more effective for anxious depression?
Panzer MJ
Ann Clin Psychiatry; 2005; 17(1):23-9. PubMed ID: 15941028
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
Pelissolo A
Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
[TBL] [Abstract][Full Text] [Related]
13. Peripheral inflammatory cytokines and immune balance in Generalised Anxiety Disorder: Case-controlled study.
Hou R; Garner M; Holmes C; Osmond C; Teeling J; Lau L; Baldwin DS
Brain Behav Immun; 2017 May; 62():212-218. PubMed ID: 28161475
[TBL] [Abstract][Full Text] [Related]
14. Comparison of first refill rates among users of sertraline, paroxetine, and citalopram.
Mullins CD; Shaya FT; Meng F; Wang J; Bron MS
Clin Ther; 2006 Feb; 28(2):297-305; discussion 296. PubMed ID: 16678651
[TBL] [Abstract][Full Text] [Related]
15. The Relationship Between Plasma Cytokine Levels and Response to Selective Serotonin Reuptake Inhibitor Treatment in Children and Adolescents with Depression and/or Anxiety Disorders.
Amitai M; Taler M; Carmel M; Michaelovsky E; Eilat T; Yablonski M; Orpaz N; Chen A; Apter A; Weizman A; Fennig S
J Child Adolesc Psychopharmacol; 2016 Oct; 26(8):727-732. PubMed ID: 26771135
[TBL] [Abstract][Full Text] [Related]
16. Effects of acute tryptophan depletion in serotonin reuptake inhibitor-remitted patients with generalized anxiety disorder.
Hood SD; Hince DA; Davies SJ; Argyropoulos S; Robinson H; Potokar J; Nutt DJ
Psychopharmacology (Berl); 2010 Feb; 208(2):223-32. PubMed ID: 19936713
[TBL] [Abstract][Full Text] [Related]
17. Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline.
Stahl SM
Biol Psychiatry; 2000 Nov; 48(9):894-901. PubMed ID: 11074227
[TBL] [Abstract][Full Text] [Related]
18. Review of sertraline and its clinical applications in psychiatric disorders.
McRae AL; Brady KT
Expert Opin Pharmacother; 2001 May; 2(5):883-92. PubMed ID: 11336629
[TBL] [Abstract][Full Text] [Related]
19. New developments in the neurobiological basis of anxiety disorders.
Gorman JM; Hirschfeld RM; Ninan PT
Psychopharmacol Bull; 2002; 36 Suppl 2():49-67. PubMed ID: 12490823
[TBL] [Abstract][Full Text] [Related]
20. Escitalopram for the treatment of GAD: efficacy across different subgroups and outcomes.
Stein DJ; Andersen HF; Goodman WK
Ann Clin Psychiatry; 2005; 17(2):71-5. PubMed ID: 16075659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
